ArticleHaematologica2014
DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia.
Article in Haematologica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 33 citations in OpenAlex.
- Adult Acute Myeloid Leukaemia WithEJHaem · 2025Article
- Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma.Cell death & disease · 2025Article
- Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.Blood advances · 2024Article
- Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion.Pediatric blood & cancer · 2024Article
- Ribosome profiling: a powerful tool in oncological research.Biomarker research · 2024Review
- MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.Nature communications · 2023Article
- The translational landscape as regulated by the RNA helicase DDX3.BMB reports · 2022Review
- Broad genomic workup including optical genome mapping uncovers aFrontiers in oncology · 2022Article
- Review
- The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.Nature communications · 2021Article
- A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML.Blood · 2021Article
- DDX3X: structure, physiologic functions and cancer.Molecular cancer · 2021Review
- Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.Blood advances · 2021Article
- Failure of tofacitinib to achieve an objective response in aCold Spring Harbor molecular case studies · 2020Article
- Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33.Translational oncology · 2019Article
- Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.Genes, chromosomes & cancer · 2017Article
- RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.Haematologica · 2016Article
- Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation.Scientific reports · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.